Congenital Bleeding Disorder
📧 Sign up to get email alerts when something new happens for Congenital Bleeding Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery [Phase 4]
Phase 4 trial update evaluating safety and efficacy of activated recombinant human factor VII in haemophilia patients with inhibitors underg…
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Research Study to Look at Side Effects During Regular Injection With Factor VIII Medicine Named Turoctocog Alfa for a 8 Weeks Period [Phase 4]
Phase 4 study assessing side effects during regular injections of Turoctocog alfa (Factor VIII) over 8 weeks in people with Haemophilia A.
-
CLINICAL_TRIALS trial_result · 2019-01-04Clinical Trial Update: Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial [Phase 2]
Phase 2 pharmacogenetic testing study of rFVIIa analogue in patients with multiple exposure days in the Adept2 trial has completed with post…
-
CLINICAL_TRIALS trial_result · 2018-09-05Clinical Trial Update: Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With Inhibitors [Phase 2]
Phase 2 trial evaluating safety and efficacy of three dosing regimens of a long-acting factor VII in haemophilia A or B patients with inhibi…
-
CLINICAL_TRIALS trial_result · 2017-07-24Clinical Trial Update: Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of NNC-0156-0000-0009 during surgical procedures in people with Haemophilia B has …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Investigation of the Pharmacokinetics of NNC172-2021, at Two Different Dose Levels, in Healthy Japanese Subjects [Phase 1]
Phase 1 pharmacokinetic study of NNC172-2021 at two dose levels in healthy Japanese subjects; trial status completed.
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B [Phase 1]
Phase 1 safety study of a 40 kDa pegylated recombinant factor IX in non-bleeding patients with Haemophilia B has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries
This completed epidemiological study sponsored by Novo Nordisk evaluates haemophilia care and orthopedic status in developing countries.
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy Volunteers [Phase 1]
A Phase 1 trial evaluating the safety and tolerability of intravenous doses of activated recombinant human factor VII in healthy volunteers.…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia [Phase 2]
This Phase 2 clinical trial update evaluates the efficacy of NovoSeven for bleeding prophylaxis in people with hemophilia, including those w…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Trial of NovoSeven® in Haemophilia - Joint Bleeds [Phase 4]
Phase 4 clinical trial update for NovoSeven in haemophilia patients with inhibitors; the study on joint bleeds has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-17Clinical Trial Update: Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX
This completed observational diary study collected data on treatment-dose patterns among patients with haemophilia A or B with inhibitors to…
-
CLINICAL_TRIALS trial_result · 2014-09-23Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of NN1731 in Healthy Volunteers [Phase 1]
Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of NN1731 in healthy volunteers to inform future development.
-
CLINICAL_TRIALS trial_result · 2013-12-06Clinical Trial Update: Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors [Phase 3]
Phase 3 trial evaluating the efficacy and safety of NNC 0078-0000-0007 in patients with congenital haemophilia with inhibitors; results have…
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Safety and Pharmacokinetics of Recombinant Factor XIII Administration in Healthy Volunteers [Phase 1]
Phase 1 trial evaluating safety and pharmacokinetics of a recombinant Factor XIII in healthy volunteers has been completed.
-
CLINICAL_TRIALS trial_result · 2011-12-19Clinical Trial Update: Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors
An observational registry evaluating NovoSeven as on-demand treatment for bleeds in patients with Hemophilia A or B with inhibitors; the stu…